Uhlmann Pac-Systeme honored with TOP 100 Award
Manufacturer of pharmaceutical packaging machines wins innovation competition
Uhlmann Pac-Systeme GmbH & Co. KG
Transparent ticket system for innovations
For Uhlmann Pac-Systeme, the world's leading system provider for the packaging of pharmaceuticals, this award is a special confirmation of its own corporate philosophy. The jury's assessment particularly highlighted the fact that the Laupheim-based company implemented 80% of all suggestions for improvement in 2023 thanks to a transparent ticket system for invention reports and continuous improvement processes. "Especially in the pharmaceutical industry, with its strict regulations and system-critical importance, innovations and their effective implementation are a central component of a safe supply of medicines. This award is therefore a great confirmation of our work and a motivation to continue looking for new ideas and approaches," says Cristian Reiter, CTO of Uhlmann Pac-Systeme.
Award on a scientific basis
The award is based on a scientific selection process in which the innovative strength of the participating companies is analyzed on the basis of more than 100 criteria, which are divided into five categories: Innovation-promoting top management, innovation climate, innovative processes and organization, external orientation/open motivation and innovation success. The aim is to determine in which companies innovations are the result of structured innovation management and do not just occur by chance. The selection process is led by innovation researcher Prof. Dr. Nikolaus Franke. He explains: "Innovation means acting instead of reacting, it means actively shaping the future instead of hoping that nothing will change."
The prize will be awarded on June 27, 2025 at a ceremony in the Rheingoldhalle in Mainz as part of the German SME Summit. The evening will be hosted by the well-known TV presenter and science journalist Ranga Yogeshwar.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.